Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-09-26 to 2023-10-18
Current total value of award: $5158.18
Description: 4562345625!TYSABRI 300 MG/15 ML VIAL 15ML